Inhibition of ANT2 may inhibit STAT3 activity by restoring SOCS1 expression and by downregulate miR-21, thereby exerting anticancer effects in human hepatocellular carcinoma cells (Jang et al., 2013a). Here, SOCS1 is linked to hepatocellular carcinoma.